Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Forge Resources Intercepts 105 G/T Au in the Payoff Zone at Alotta Project, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Ownership  |  Insiders

Stock Quote Today & Recent News GRI Bio Inc GRI

Healthcare Biotechnology
GRI Bio, Inc. is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. The Company’s therapies are designed to target the activity of Natural Killer T (NKT) cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GRI)

GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")

GlobeNewswire September 11, 2025

GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire September 3, 2025

GRI Bio to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

GlobeNewswire August 14, 2025

GRI Bio CEO, Marc Hertz, Participates in Virtual Investor "What This Means" Segment

GlobeNewswire July 31, 2025

GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF") 

GlobeNewswire July 31, 2025

GRI Bio Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference

GlobeNewswire July 22, 2025

JTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live

ACCESS Newswire July 22, 2025

GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis ("IPF")

GlobeNewswire July 1, 2025

GRI Bio's GRI-0621 Demonstrates Encouraging Safety Results at Planned Interim 6-Week Analysis in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")

GlobeNewswire June 26, 2025
View More News ››

Opinion & Analysis (NDAQ:GRI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:GRI)

GRI....$2.06 now

Dodo bird in the making ; )
Iseneschal - September 11, 2025

GRI....Great Morning

Bot the L.O.D and just sold the Rip over $2.20 Scalped Maddapakka !
Iseneschal - September 11, 2025

GRI....Good Morning !

sold all
Iseneschal - September 11, 2025

RE:RE:GRI....might want to watch this ; )

Just tapped $1.6797 which is N.H.O.D....vols have been increasing all morning....but still not a "blow off" IMHO Expect the...
Iseneschal - September 5, 2025

RE:GRI....might want to watch this ; )

Slowly Slowly creeps the monkey.... $1.65 H.O.D this a.m....still watching with a small position. Cheers !
Iseneschal - September 5, 2025

GRI....trending slightly higher on low vol

$1.39 bid...offered at $1.41 Looking for a vol spike and break of $1.50
Iseneschal - August 14, 2025
View more Bullboard ››

Forge Resources Corp.

Forge Resources Corp.

Forge Resources Corp. is a junior exploration company. The Company is engaged in the business of the exploration and ...
View More »